Dear Customer: GlaxoSmithKline is recalling the Ventolin HFA Inhaler lots listed below from the retail level. These lots are being recalled due to the potential that a very low level of canisters may not contain sufficient propellant to deliver the labeled claim of 60 actuations. Patients requiring treatment for increased symptoms of bronchospasm (i.e. shortness of breath, wheezing, chest tightness) but not receiving medication could potentially need to seek additional medical help.
Ventolin HFA Inhaler Sample - 60 Actuations
Ventolin HFA Inhaler Sample - 60 Actuations
Ventolin HFA Inhaler Sample - 60 Actuations
Ventolin HFA Inhaler Sample - 60 Actuations
Ventolin HFA Inhaler Sample - 60 Actuations
Ventolin HFA Inhaler Institutional Pack – 60 Actuations
Ventolin HFA Inhaler Institutional Pack – 60 Actuations
Ventolin HFA Inhaler Institutional Pack – 60 Actuations
Ventolin HFA Inhaler Institutional Pack – 60 Actuations
Ventolin HFA Inhaler Institutional Pack – 60 Actuations
Recalled product was shipped between September 23, 2011 and January 10, 2012. Stop distributing and immediately quarantine all listed Ventolin HFA Inhaler lots. Please carry out a physical count and record this data on the business reply card and the packing slip which are included with this letter. Please examine your inventory immediately and return all units ofthe listed Ventolin HFA Inhaler lots along with the business reply card to GlaxoSmithKline, c/o Stericycle using the enclosed UPS Return Label to 2670 Executive Drive, Suite A, Indianapolis, IN 46241. It is very important that you complete the requested information on the enclosed postage paid Business Reply Card and return it to us within five (5) business days, even if you do not have the listed Ventolin HFA Inhaler lots in stock. Thank you for your cooperation. For shipping assistance or questions about the recall process, please contact Stericycle at 888-548-8521. Reimbursement will be issued at the price in effect at the time of purchase. In addition, reimbursement will also include a service and handling payment based on the HDMA guidelines. Stericycle is actively notifying customer accounts. Credit or reimbursement for any additional notifications to dispensing entities will not be provided.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. We appreciate your immediate attention and cooperation. GlaxoSmithKline remains committed to product quality, integrity, and patient satisfaction and we sincerely regret any inconvenience this action may cause. Enclosures:
Packing Slip and Prepaid UPS Return Service Shipping Label
Available online at www.sciencedirect.comIntra-articularly applied pulsed radiofrequency can reduce chronicknee pain in patients with osteoarthritisHaktan Karaman , Adnan Tu¨fek , Go¨nu¨l Oa Department of Anesthesiology, Pain Management Center, Dicle University, Diyarbakir, Turkeyb Department of Anesthesiology, Dicle University, Diyarbakir, Turkeyc Diyarbakir Vocational Higher School,
401-410 Employee Handbook Administrative Manual 407 Drug and Alcohol Testing 7.1 Purpose The purpose of these policies is to establish compliance with the Federal Highway Administration regulations requiring drug and alcohol testing for commercial driver's license (CDL) holders. Regulations issued by the United States Department of Transportation mandate urine drug and evident
Ventolin HFA Inhaler – 60 Actuations – NDC 0173-0682-21